Natalia Kolerova became the Oncology General Manager at Novartis in April 2014. In this position she supervised the development of the oncological segment in Russia, Ukraine and the CIS. Since 2017, she also holds the position of General Director at Novartis Pharma LLC in Russia.
Natalia joined Novartis in 2008 as the head of a new business unit of specialized medicine. In this position, she managed to efficiently organize the operations of the unit and successfully bring six new products to the Russian market, including Galvus® and Gilenya®. Later, Natalya headed the unit of introducing pharmaceutical products into the market, where she supervised the accessibility of pharmaceuticals from the company’s oncology portfolio at the federal and regional levels.
Natalia graduated from the Sechenov Moscow Medical Academy with a degree in Pharmacology, as well as the Lomonosov Moscow State University with a degree in Sociology. She holds an MBA degree.
Before joining Novartis, Natalia held senior positions at the Russian representative offices of the international pharmaceutical companies Abbott Lab SA and Sanofi-Aventis.